| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.0065 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |